Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors. [electronic resource]
Producer: 20140430Description: 507-17 p. digitalISSN:- 1476-5551
- Agammaglobulinaemia Tyrosine Kinase
- Cell Transplantation
- Hematopoietic Stem Cell Transplantation
- Humans
- Immune Tolerance -- drug effects
- Immunotherapy
- Lenalidomide
- Leukemia, Lymphocytic, Chronic, B-Cell -- therapy
- Protein Kinase Inhibitors -- pharmacology
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Thalidomide -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.